Gainers
- Pulmonx LUNG shares rose 29.5% to $10.0 during Wednesday's after-market session. The market value of their outstanding shares is at $388.1 million. The company's, Q1 earnings came out today.
- Butterfly Network BFLY shares moved upwards by 18.15% to $0.93. The company's market cap stands at $193.5 million. As per the press release, Q1 earnings came out today.
- Compass Therapeutics CMPX stock rose 11.46% to $1.75. The market value of their outstanding shares is at $240.7 million.
- Sharps Technology STSS shares increased by 9.2% to $0.27. The market value of their outstanding shares is at $4.2 million.
- Blueprint Medicines BPMC shares moved upwards by 6.47% to $101.0. The market value of their outstanding shares is at $6.3 billion.
- Asensus Surgical ASXC stock rose 6.32% to $0.25. The market value of their outstanding shares is at $69.0 million.
Losers
- Envista Holdings NVST stock decreased by 12.5% to $17.29 during Wednesday's after-market session. The company's market cap stands at $2.9 billion. As per the press release, Q1 earnings came out today.
- Accuray ARAY shares declined by 12.45% to $1.9. The market value of their outstanding shares is at $188.4 million. As per the news, the Q3 earnings report came out today.
- Allakos ALLK stock declined by 9.74% to $1.02. The market value of their outstanding shares is at $90.3 million.
- Psyence Biomedical PBM shares decreased by 7.5% to $1.11. The market value of their outstanding shares is at $14.8 million.
- Schrodinger SDGR stock fell 7.37% to $23.4. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out today.
- Indaptus Therapeutics INDP stock fell 6.94% to $1.88. The company's market cap stands at $16.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in